This program utilizes a community-engaged research approach to implementing and evaluating a program that seeks to reduce sexual risk behavior among Black adult heterosexual men. The investigators aims are to assess the impact of this linguistically and culturally tailored HIV prevention program on the sexual risk of heterosexual, African American men aged 18 and older, to assess the intervention's impact on the more proximal social and psychosocial variables that the program is designed to change, and to identify key contextual level factors that may impact the intervention's impact across segments of this priority population.

Barbershops are assigned to either experimental or active control condition. Men recruited from experimental barbershops receive a single-session group intervention focused on HIV prevention.

Behavioral: BTWB intervention

Men work in groups to complete a intervention that takes approximately two hours to complete.

Active Comparator: Cancer prevention and screening

Barbershops are assigned to either experimental or control condition. Men recruited from control barbershops receive information on cancer prevention and control.

Behavioral: Cancer prevention and screening

Men are provided health education about cancer screening and prevention

Eligibility

Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Unprotected sex in the past three months

Identify as Black or African American

Exclusion Criteria:

Having been in an HIV prevention research study in the last six months

Reporting a history in the past five years of injection drug use

Reporting a history in the past five years of having sex with other men

Reporting an HIV-positive serostatus

Inability to understand spoken English.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01980771